Voice your opinion on congressional bill HR4438-118 and let lawmakers know your stance with UnPac!

Main Subject: Health

John W. Walsh Alpha-1 Home Infusion Act of 2023

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

House committee actions Actions

Committee
Jul. 07 2023	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Jun. 30
2023

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Jun. 30 2023	Introduced in House Introduced in House

House bill HR4438-118

John W. Walsh Alpha-1 Home Infusion Act of 2023

House bill HR4438-118

John W. Walsh Alpha-1 Home Infusion Act of 2023

Promote the cause!

Or use this QR code